Entering text into the input field will update the search result below

ProMIS Neurosciences to commence trading on Nasdaq

Jul. 08, 2022 7:47 AM ETPMNBy: Deepa Sarvaiya, SA News Editor
  • ProMIS Neurosciences (OTCQB:ARFXD) receives final approval to list its common shares on Nasdaq on Friday, July 8th, 2022, under the symbol “PMN”.
  • The company’s common shares will continue to trade on the TSX under the same symbol “PMN” (its current symbol). Concurrent with the listing of ProMIS’ common shares on Nasdaq, the common shares will cease to be quoted on the OTCQB.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.